Bandana Sharan
Director
Oncology
APAC Biotech
India
Biography
Dendritic Cell therapy has tremendous potential to improve the lifespan of cancer affected folks across the globe, especially in a developing country like ours. Realizing the great potential of DC therapy in the field of Oncology, APAC Biotech (P) Ltd. was established at Gurgaon. We have come a long way since starting our journey in 2010. Continuing the fine traditions of dendritic cell research, our laboratory offers arguably the best formulation in the field of cancer treatment for real world impact, based on a foundation of excellence in research. The research activities at the lab cover a wide spectrum of activities, including dendritic cell research to develop a formulation for the treatment of cancer patients. After our concerted efforts on research and approvals from leading hospitals across India we initiated with in vitro studies followed by trials in 2011 and since then there has been no looking back. We believe that in today’s world true innovation has to be open, collaborative, global and multi-disciplinary. We work closely with leading oncologists, specialized medical advisors, research organizations, hospitals and regulatory bodies. Taking collaborative innovation to the next level we have come up with a new research study in Recombinant Proteins
Research Interest
Oncology